Back to Business

H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on trial completion

Business September 2, 2026 at 11:50 AM

H.C. Wainwright reiterates Telix Pharmaceuticals stock rating on trial completion

Investing.com

Read at Investing.com

More Stories

U.S. private sector job growth underwhelms with 38K gain

U.S. private sector job growth underwhelms with 38K gain

🇺🇸 Investing.com 38m ago

Bernstein raises MongoDB stock price target to $484 on strong results

Bernstein raises MongoDB stock price target to $484 on strong results

🇺🇸 Investing.com 39m ago

Bernstein raises Dell stock price target to $650 on storage strength

Bernstein raises Dell stock price target to $650 on storage strength

🇺🇸 Investing.com 39m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play